{"id":"NCT02814916","sponsor":"AbbVie","briefTitle":"Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA","officialTitle":"A Phase 3, Multicenter, Open-Label, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-03-30","primaryCompletion":"2024-01-01","completion":"2024-01-01","firstPosted":"2016-06-28","resultsPosted":"2024-09-19","lastUpdate":"2024-09-19"},"enrollment":199,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Methicillin-Resistant Staphylococcus Aureus","Bacterial Infections","Staphylococcal Skin Infections"],"interventions":[{"type":"DRUG","name":"Dalbavancin","otherNames":["Xydalba"]},{"type":"DRUG","name":"Vancomycin","otherNames":[]},{"type":"DRUG","name":"Oxacillin","otherNames":[]},{"type":"DRUG","name":"Flucloxacillin","otherNames":[]},{"type":"DRUG","name":"Cefadroxil","otherNames":[]},{"type":"DRUG","name":"Clindamycin","otherNames":[]}],"arms":[{"label":"Dalbavancin single-dose","type":"EXPERIMENTAL"},{"label":"Dalbavancin two-dose","type":"EXPERIMENTAL"},{"label":"Comparator","type":"ACTIVE_COMPARATOR"}],"summary":"To determine the safety and descriptive efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections in children, aged birth to 17 years (inclusive), known or suspected to be caused by susceptible Gram-positive organisms, including methicillin-resistant strains of Staphylococcus aureus.","primaryOutcome":{"measure":"Shift From Baseline in Distortion Product Otoacoustic Emission at TOC Visit","timeFrame":"Baseline, Day 28 (Â± 2 days)","effectByArm":[{"arm":"Dalbavancin Single-dose","deltaMin":2,"sd":null},{"arm":"Comparator","deltaMin":1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"0 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":null},"locations":{"siteCount":84,"countries":["United States","Argentina","Belarus","Brazil","Bulgaria","Chile","Colombia","Georgia","Greece","Guatemala","Latvia","Lithuania","Mexico","Panama","Poland","Romania","Russia","South Africa","Spain","Ukraine"]},"refs":{"pmids":[],"seeAlso":["https://www.rxabbvie.com/"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":91},"commonTop":["VOMITING","PYREXIA","NASOPHARYNGITIS","ANAEMIA POSTOPERATIVE","COUGH"]}}